Intraoperative radiotherapy in stage IIB adenocarcinoma of the uterine cervix: a retrospective study

Objectives Adenocarcinoma (AC) of the uterine cervix has a poor prognosis and is usually fatal. The aim of this study was to evaluate the clinical outcome and toxicity of intraoperative electron beam radiation therapy (IOERT) in advanced AC. Methods Twenty-seven women were treated with IOERT. Surgery consisted of gross negative surgical margins in 19 patients, positive surgical margins in two patients, and close surgical margins in six patients. Twenty-three patients received chemotherapy. Results The 5-year overall survival and disease-free survival rates were 21/27 (77.8%) and 19/27 (70.4%), respectively. A significantly better survival rate was found in patients with AC compared to patients with adenosquamous carcinoma. Tumor recurrence and metastasis were observed in seven patients (25.9%). No central failure occurred whether or not the resection margins were positive. Two (7.4%) patients developed peripheral neurotoxicity. Conclusion IOERT plus surgery may be feasible and effective with a low risk of toxicity, even in patients with positive resection margins.

[1]  L. Gunderson.  Rationale for and results of intraoperative radiation therapy , 1994, Cancer.

[2]  J. Wang,et al.  Intraoperative Electron Beam Radiotherapy for Primary Treatment of Stage IIB Cervical Cancer: A Retrospective Study , 2012, The Journal of international medical research.

[3]  W. Hop,et al.  Prognostic factors in adenocarcinoma of the uterine cervix. , 2004, Gynecologic oncology.

[4]  R. Zaino,et al.  A phase III randomized trial of postoperative pelvic irradiation in Stage IB cervical carcinoma with poor prognostic features: follow-up of a gynecologic oncology group study. , 2006, International journal of radiation oncology, biology, physics.

[5]  P. Grigsby,et al.  Rethinking the use of radiation and chemotherapy after radical hysterectomy: a clinical-pathologic analysis of a Gynecologic Oncology Group/Southwest Oncology Group/Radiation Therapy Oncology Group trial. , 2005, Gynecologic oncology.

[6]  G. Thomas,et al.  Adenocarcinoma: a unique cervical cancer. , 2010, Gynecologic oncology.

[7]  F. Sim,et al.  Radical pelvic resection and intraoperative radiation therapy for recurrent endometrial cancer: technique and analysis of outcomes. , 2006, Gynecologic oncology.

[8]  M. Quinn.  Adenocarcinoma of the cervix--are there arguments for a different treatment policy? , 1997, Current opinion in obstetrics & gynecology.

[9]  B. Rosen,et al.  Does histology influence prognosis in patients with early‐stage cervical carcinoma? , 2001, Cancer.

[10]  C. Willett,et al.  Intraoperative electron beam radiation therapy for retroperitoneal soft tissue sarcoma , 1991, Cancer.

[11]  S. Dowdy,et al.  Long-term outcomes with intraoperative radiotherapy as a component of treatment for locally advanced or recurrent uterine sarcoma. , 2012, International journal of radiation oncology, biology, physics.

[12]  A. Singer,et al.  Cervical cancer: effect of glandular cell type on prognosis, treatment, and survival. , 2003, Obstetrics and gynecology.

[13]  Juan Wang,et al.  Intraoperative radiotherapy electron boost in advanced and recurrent epithelial ovarian carcinoma: a retrospective study , 2011, BMC Cancer.

[14]  J. Carlson,et al.  Adenosquamous histology predicts a poor outcome for patients with advanced‐stage, but not early‐stage, cervical carcinoma , 2003, Cancer.

[15]  F. Calvo,et al.  Intraoperative radiotherapy electron boost followed by moderate doses of external beam radiotherapy in resected soft-tissue sarcoma of the extremities. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[16]  P. Tran,et al.  Long-term survivors using intraoperative radiotherapy for recurrent gynecologic malignancies. , 2007, International journal of radiation oncology, biology, physics.

[17]  P Grigsby,et al.  Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  M. Sherman,et al.  Pathological characteristics of cervical adenocarcinoma in a multi-center US-based study. , 2007, Gynecologic oncology.

[19]  M. Sherman,et al.  Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976–2000 , 2004, Cancer.

[20]  B. Monk,et al.  Randomized comparison of weekly cisplatin or protracted venous infusion of fluorouracil in combination with pelvic radiation in advanced cervix cancer: a gynecologic oncology group study. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  M. Sherman,et al.  Pathological characteristics of cervical adenocarcinoma in a multi-center U.S.-based study , 2006 .